1) Nakane PK, Pierce GG:Enzyme-labeled antibodies:Preparation and application of antigens. J Histochem Cytochem 14:928-931, 1966
2) Lukes RJ, Collin RD:Immunologic characterization of human malignant lymphoma. Cancer 34:1488-1503, 1974
3) Gerard-Marchant R, Hamalin I, Lennert K, et al:Classification of non-Hodgkin lymphoma. Lancet Ⅱ:406-408, 1974
4) Lennert K, Mohri N:Histopathology and diagnosis of non-Hodgkin's lymphoma. In:Malignant Lymphomas Other than Hodgkin's Disease. Hb spez path Anat Hist Ⅰ/3, Springer Verlag, Berlin, pp111-469, 1978
5) 毛利昇,齋藤生朗:悪性リンパ腫の組織学的分類 その歴史的変遷.胃と腸 28:999-1006, 1993
6) Jaffe E, Harris NL, Stein H, et al:Tumours of Heamatopoetic and Lymphoid Tissue:IARC Press, Lyon, 2001
7) 竹内賢吾:濾胞性リンパ腫.最新悪性リンパ腫アトラス(菊池昌弘,森茂郎編),文光堂,pp141-153, 2004
diffuse large B-cell lymphoma:a clinicopathologic study of 109 patients. Blood 99:815-821, 2002
9) Ohshima K, Kawasaki C, Muta H, et al:CD10 and Bcl-2 expression in diffuse large B-cell lymphoma:CD10 is marker of improved prognosis. Histopathol 39:156-162, 2001
10) 竹内賢吾:びまん性大細胞型B細胞性リンパ腫.新WHO分類による白血病・リンパ系腫瘍の病態学(森茂郎監修),中外医学社,pp172-179, 2004
11) Alizadeh AA, Eisen MB, Davis RE, et al:Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000
12) Chang CC, McClintock S, Cleveland RP, et al:Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 28:464-470, 2004
13) Hans CP, Weisenburger DD, Greiner TC, et al:Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282, 2004
14) 中村直哉:バーキットリンパ腫/白血病.最新悪性リンパ腫アトラス(菊池昌弘,森茂郎編),文光堂,pp190-196, 2004
15) Attygalle A, Al-Jehani R, Diss TC, et al:Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99:627-633, 2002
16) 田丸淳一:ホジキンリンパ腫.最新悪性リンパ腫アトラス(菊池昌弘,森茂郎編),文光堂,pp281-292, 2004